Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir

nork Ouwerkerk-Mahadevan, Sivi, Snoeys, Jan, Peeters, Monika, Beumont-Mauviel, Maria, Simion, Alexandru
Argitaratua izan da Clin Pharmacokinet (2015)

Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment

nork Ouwerkerk-Mahadevan, Sivi, Beumont-Mauviel, Maria, Mortier, Steven, Peeters, Monika, Verloes, Rene, Truyers, Carla, Mannens, Geert, Wynant, Inneke, Simion, Alexandru
Argitaratua izan da Drugs R D (2015)

Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis

nork Montes, Marisa, Nelson, Mark, Marie Girard, Pierre, Sasadeusz, Joe, Horban, Andrzej, Grinsztejn, Beatriz, Zakharova, Natalia, Rivero, Antonio, Lathouwers, Erkki, Janssen, Katrien, Ouwerkerk-Mahadevan, Sivi, Witek, James
Argitaratua izan da J Int AIDS Soc (2014)

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications

nork Marra, Fiona, Höner zu Siederdissen, Christoph, Khoo, Saye, Back, David, Schlag, Michael, Ouwerkerk‐Mahadevan, Sivi, Bicer, Ceyhun, Lonjon‐Domanec, Isabelle, Jessner, Wolfgang, Beumont‐Mauviel, Maria, Kalmeijer, Ronald, Cornberg, Markus
Argitaratua izan da Br J Clin Pharmacol (2018)

Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbu...

nork Bourgeois, Stefan, Horsmans, Yves, Nevens, Frederik, van Vlierberghe, Hans, Moreno, Christophe, Beumont, Maria, Vijgen, Leen, van Eygen, Veerle, Luo, Donghan, Hillewaert, Vera, Van Remoortere, Pieter, van de Logt, Jolanda, Ouwerkerk-Mahadevan, Sivi
Argitaratua izan da Antimicrob Agents Chemother (2017)